Among adults with prediabetes, lifestyle intervention, but not metformin, was associated with a lower burden of multimorbidity during 21 years of follow-up, which highlights the importance of ...
The FDA has accepted Camurus' resubmitted NDA for CAM2029 (octreotide) extended-release injection for acromegaly, setting a PDUFA date of December 18, 2026.
Prepregnancy obesity was associated with increased risk for preeclampsia and eclampsia, but the magnitude of this risk varies significantly across racial and ethnic groups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results